Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 10, 2007, Pages 1076-1082

  Khaleeli, Z ^a   Sastre Garriga, J ^a   Ciccarelli, O ^a   Miller, D H ^a   Thompson, A J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WALKING; WHITE MATTER; ATROPHY; BRAIN; MIDDLE AGED; NEUROLOGIC EXAMINATION; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

ADULT; ATROPHY; BRAIN; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; NEUROLOGIC EXAMINATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 34548647704     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.107565     Document Type: Article

References (42)

1. Thompson A. Overview of primary progressive multiple sclerosis (PPMS):similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis. Mult Scler 2004;10(Suppl 1):S2-7.
2. Ingle GT, Stevenson VL, Miller DH, et al. Primary progressive multiple sclerosis: a 5-year clinical and MR study. Brain 2003;126:2528-36.
3. Filippi M, Rovaris M, Rocca MA. Imaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques. Mult Scler 2004;10(Suppl 1):S36-44.
4. van Waesberghe JH, Kamphorst W, De Groot CJ, ef al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747-54.
5. Schmierer K, Scaravilli F, Altmann DR, ef al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004;56:407-15.
6. Tofts P. Quantitative MRI of the brain. Chichester: John Wiley &Sons, 2004.
7. Ramio-Torrenta L, Sastre-Garriga J, Ingle GT, et al. Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study. J Neurol Neurosurg Psychiatry 2006;77:40-5.
8. Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000;47:831-5.
9. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444- 52.
10. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122(Pt 5):871-82.
11. Barker GJ, Tofts PS, Gass A. An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio. Magn Reson Imaging 1996;14:403-11.
12. Plummer D. Dispimage: a display and analysis tool for medical images. Rev Neuroradiol 1992;5:489-95.
13. ChardDT, Parker GJ, Griffin CM, et al. The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology. J Magn Reson Imaging 2002;15:259-67.
14. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998;316:1236-8.
15. Ellison GW, Myers LW, Leake BD, et al. Design strategies in multiple sclerosis clinical trials. The Cyclosporine Multiple Sclerosis Study Group. Ann Neurol 1994;36(Suppl):S108-12.
16. Hoogervorst EL, Eikelenboom MJ, Uitdehaag BM, et al. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report. J Neurol Neurosurg Psychiatry 2003;74:439-42.
17. Hoogervorst EL, Kalkers NF, Uitdehaag BM, et al. A study validating changes in the multiple sclerosis functional composite. Arch Neurol 2002;59:113-16.
18. Greenhalgh T. How to read a paper. Papers that report diagnostic or screening tests. BMJ 1997;315:540-3.
19. Audoin B, Fernando KT, Swanton JK, et al. Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis. Brain 2006;129:1031-9.
20. Chard DT, Griffin CM, Parker GJ, et al. Brain atrophy in clinically early relapsing- remitting multiple sclerosis. Brain 2002;125:327-37.
21. Tombaugh TN. A comprehensive review of the Paced Auditory Serial Addition Test (PASAT). Arch Clin Neuropsychol 2006;21:53-76.
22. Solari A, Radice D, Manneschi L, et al. The multiple sclerosis functional composite: different practice effects in the three test components. J Neurol Sci 2005;228:71-4.
23. Hobart J, Freeman J, Thompson A. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 2000;123(Pt 5):1027-40.
24. Hobart J, Kalkers N, Barkhof F, et al. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite. Mult Scler 2004;10:41-6.
25. Agosta F, Rovaris M, Pagani E, et al. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006;129:2620-7.
26. Filippi M, Bozzali M, Horsfield MA, et al. A conventional and magnetization transfer MRI study of the cervical cord in patients with MS. Neurology 2000;54:207-13.
27. Rovaris M, Filippi M, Minicucci L, et al. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol 2000;21 :402-8.
28. Lucchinetti C, Bruck W. The pathology of primary progressive multiple sclerosis. Muit Scier 2004;10(Suppl 1):S23-30.
29. Davies GR, Altmann DR, Hadjiprocopis A, et al. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. J Neurol 2005;252:1037-44.
30. Fernando KT, Tozer DJ, Miszkiel KA, et al. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2005;128:2911-25.
31. Rovaris M, Gallo A, Valsasina P, et al. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI. Neuroimage 2005;24:1139-46.
32. Kutzelnigg A, Lassmann H. Cortical lesions and brain atrophy in MS. J Neurol Sci 2005;233:55-9.
33. Kidd D, Barkhof F, McConnell R, et al. Cortical lesions in multiple sclerosis. Brain 1999;122(Pt 1):17-26.
34. Bruck W, Stadelmann C. The spectrum of multiple sclerosis: new lessons from pathology. Curr Opin Neurol 2005;18:221-4.
35. Geurts JJ. Imaging cortical lesions and NAGM at high and standard field strength: combined post-mortem MRI and histopathology. ECTRIMS conference 2005, Thessaloniki, Greece, 28 Sept-1 Oct 2005, S8, abstract 40. (4.7T and 1.5T).
36. Geurts JJ, Bo L, Pouwels PJ, et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005;26:572-7.
37. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128:2705-12.
38. Sastre-Garriga J, Ingle GT, Chard DT, et al. Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. Brain 2005;128:1454-60.
39. Davies GR, Altmann DR, Hadjiprocopis A, et al. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. J Neurol 2005;252:1037-44.
40. Rovaris M, Judica E, Gallo A, et al. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain 2006;129:2628-34.
41. Rovaris M, Bozzali M, Rodegher M, et al. Brain MRI correlates of magnetization transfer imaging metrics in patients with multiple sclerosis. J Neurol Sci 1999;166:58-63.
42. Phillips MD, Grossman RI, Miki Y, et al. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. AJNR Am J Neuroradiol 1998;19:1055-60.